erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Malke H Transfer of a plasmid mediating antibiotic resistance between strains of Streptococcus pyogenes in mixed cultures. 1975 Z. Allg. Mikrobiol. pmid:769365
Malke H Interaction of chromosomal mutations to erythromycin resistance with plasmid-mediated resistance to erythromycin and lincomycin in Streptococcus pyogenes. 1977 Z. Allg. Mikrobiol. pmid:337688
Osman HG et al. Utilization of Egyptian raw by-products for the erythromycin production by Streptomyces erythreus. 1968 Z. Allg. Mikrobiol. pmid:4989340
Malke H Transductional analysis of resistance to lincomycin and erythromycin in Streptococcus pyogenes. 1972 Z. Allg. Mikrobiol. pmid:4568554
Dworsky P [Effect of inhibitors of protein and nucleic acid synthesis on the shape of the nucleoid of Escherichia coli]. 1974 Z. Allg. Mikrobiol. pmid:4142904
Schuhmann E and Taubeneck U [L forms of Escherichia coli K 12 (lambda). I. Induction and mode of multiplication]. 1971 Z. Allg. Mikrobiol. pmid:4107077
Osman HG et al. Factors influencing the biosynthesis of erythromycin by Streptomyces erythreus. 1968 Z. Allg. Mikrobiol. pmid:4916831
Koopman JP et al. Influence of the antibiotics roxithromycin and erythromycin on the gastro-intestinal ecology of mice. 1987 Z Versuchstierkd pmid:3324551
Baumüller A et al. [Bacterial prostatitis--therapeutic principles]. 1977 Z Urol Nephrol pmid:919805
Busch H and Unger K [Studies on pathogen spectra and resistance quotas of infection producing organisms in surgical and urologic diseases in common hospitalization and separate ambulatory settings]. 1975 Z Urol Nephrol pmid:775851
BESZNYAK I et al. [THE ANTIBIOGRAM OF THORACIC EMPYEMA AND ITS LOCAL ANTIBIOTIC THERAPY]. 1964 Z Tuberk Erkr Thoraxorg pmid:14141375
BALDAMUS U [Antibiotic treatment of unspecific plombage empyema]. 1956 Z Tuberk pmid:13353453
Quincke G [Sensitivity to penicillin of gonococcal strains isolated in Lomé, Togo]. 1970 Z Tropenmed Parasitol pmid:4992455
Pulverer G [Studies with lysotaphin. II. Lysostaphin sensitivity of 230 strains of Staph. aureus of animal origin]. 1968 Z Med Mikrobiol Immunol pmid:5751715
Kayser FH [Effect of benzylpenicillin and ampicillin on enterococci]. 1971 Z Med Mikrobiol Immunol pmid:5554809
Pulverer G [Studies with lysostaphin. I. Lysostaphin sensitivity of 355 strains of Staph. aureus of human origin]. 1968 Z Med Mikrobiol Immunol pmid:5710870
Goldmann SF and Heiss F [The phenomenom of resistance and cross resistance to erythromycin, lincomycin and staphylomycin]. 1971 Z Med Mikrobiol Immunol pmid:4929058
Zierfels G and Petz M [Fluorimetric determination of erythromycin residues in foods of animal origin after derivatization with FMOC and HPLC separation]. 1994 Z Lebensm Unters Forsch pmid:8197827
Bláhová O and Drastík J [Antibiotics for recurrent acute otitis media in infants under two (author's transl)]. 1973 Z Laryngol Rhinol Otol pmid:4149361
Windorfer A and Mihailova K [Influence of various drugs and pH-values on albumin-bilirubin binding in vitro]. 1973 Z Kinderheilkd pmid:4686270
Mochmann H et al. [The sensitivity of B. pertussis to antibiotics. Examination of 122 patients' strains of B. pertussis]. 1969 Z Kinderheilkd pmid:4315563
Krauer-Mayer B [Antibacterial therapy in the newborn infant]. 1967 Z Kinderheilkd pmid:4297705
ZINZIUS J [Some side-effects of erythromycin]. 1955 Z Haut Geschlechtskr pmid:13257371
Landes E and Metz B [Syphilis therapy in penicillin incompatibility]. 1970 Z Haut Geschlechtskr pmid:5505299
DORN H [Lymphogranuloma venereum (primary lesion, late stage, treatment with erycinum)]. 1956 Z Haut Geschlechtskr pmid:13353318
WEISE HJ [Experiences with erythromycin in some skin diseases]. 1956 Z Haut Geschlechtskr pmid:13353333
Hudemann H [Staphylococci and mycoses as a cause of diarrhea]. 1974 Z Gesamte Inn Med pmid:4617437
Hirschelmann R and Bekemeier H [Anti-inflammatory effects of chemotherapeutics and antibiotics]. 1973 Z Gesamte Inn Med pmid:4779148
Tauchnitz C [Current status of antibiotic therapy]. 1973 Z Gesamte Inn Med pmid:4349582
Gebhart A and Cervený R [Contribution to the problem of staphylococcal enterocolitis]. 1966 Z Gesamte Inn Med pmid:5986532
Peeters TL [The potentials of erythromycin derivatives in the treatment of gastrointestinal motility disorders]. 1991 Z Gesamte Inn Med pmid:1926941
FRICKE G [Results with erycinum in internal diseases]. 1957 Z Gesamte Inn Med pmid:13468608
Tauchnitz C [Expedient therapy of chronic pyelonephritis]. 1970 Z Gesamte Inn Med pmid:4331735
Dittmer A [Use of antibiotics--principles and possibilities]. 1984 Z Gesamte Hyg pmid:6324502
Winkler M et al. [Puerperium after threatened premature labor--effects of infection screening in pregnancy]. 1994 Mar-Apr Z Geburtshilfe Perinatol pmid:8023535
Hoppe JE [Whooping cough in pregnant patients and newborn infants]. 1996 Nov-Dec Z Geburtshilfe Neonatol pmid:9081753
VON KOBYLETZKI D and STRAUCH [EXPERIMENTAL STUDIES ON THE PROBLEM OF DIAPLACENTAL PASSAGE AND THE EXCRETION OF ERYTHROMYCIN-ESTOLATE (PELS) WITH HUMAN MILK]. 1964 Z Geburtshilfe Gynakol pmid:14198621
Folwaczny C et al. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma]. 1997 Z Gastroenterol pmid:9432812
Wienbeck M and Barnert J [Principles of pharmacotherapy]. 1990 Z Gastroenterol pmid:2162581
Bassotti G et al. Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation. 1998 Z Gastroenterol pmid:9577904
Schusdziarra V [Motilin and motilides--future perspectives for therapy of gastrointestinal motility disorders]. 1992 Z Gastroenterol pmid:1413940
Griga T et al. [Effect of stomach motility on measuring stomach permeability with saccharose in vivo]. 1999 Z Gastroenterol pmid:10378362
Neubrand M and Sauerbruch T Erythromycin, a motilin agonist, increases postprandial gallbladder emptying during therapy with ursodeoxycholic acid. 1998 Z Gastroenterol pmid:9612923
Naumann G [The detection of the agent of Legionnaires' disease--a confirmation of Koch's postulates]. 1983 Z Erkr Atmungsorgane pmid:6356647
Fischer P and Schilling W [Therapeutic results in lung diseases caused by atypical mycobacteria]. 1984 Z Erkr Atmungsorgane pmid:6202070
Kirsten D and Meister W [Present possibilities of antibiotic therapy in chronic non-specific respiratory diseases (author's transl)]. 1976 Z Erkr Atmungsorgane pmid:1049185
Ocklitz HW et al. [Pediatric guidelines. 3. Antibiotics--indications]. 1968 Z Arztl Fortbild (Jena) pmid:4978334
Dietzsch HJ et al. [Abscessed (staphylococcal) pneumonia in childhood]. 1972 Z Arztl Fortbild (Jena) pmid:4118084
Handrick W et al. [Contribution to the diagnosis and therapy of juvenile pneumonia]. 1981 Z Arztl Fortbild (Jena) pmid:7340181
Heite HJ [Therapy of venereal infections]. 1971 Z Allgemeinmed pmid:5108596